Outcomes Research in Review

Coronary CT Angiography Compared to Coronary Angiography or Standard of Care in Patients With Intermediate-Risk Stable Chest Pain

SCOT-HEART Investigators, Newby DE, Adamson PD, Berry C, et al. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018;379(1):924-933. doi:10.1056/ NEJMoa1805971

DISCHARGE Trial Group, Maurovich-Horvat P, Bosserdt M, Kofoed KF, et al. CT or invasive coronary angiography in stable chest pain. N Engl J Med. 2022;386(17):1591-1602. doi:10.1056/ NEJMoa2200963


 

References

Study 1 Overview (SCOT-HEART Investigators)

Objective: To assess cardiovascular mortality and nonfatal myocardial infarction at 5 years in patients with stable chest pain referred to cardiology clinic for management with either standard care plus computed tomography angiography (CTA) or standard care alone.

Design: Multicenter, randomized, open-label prospective study.

Setting and participants: A total of 4146 patients with stable chest pain were randomized to standard care or standard care plus CTA at 12 centers across Scotland and were followed for 5 years.

Main outcome measures: The primary end point was a composite of death from coronary heart disease or nonfatal myocardial infarction. Main secondary end points were nonfatal myocardial infarction, nonfatal stroke, and frequency of invasive coronary angiography (ICA) and coronary revascularization with percutaneous coronary intervention or coronary artery bypass grafting.

Main results: The primary outcome including the composite of cardiovascular death or nonfatal myocardial infarction was lower in the CTA group than in the standard-care group at 2.3% (48 of 2073 patients) vs 3.9% (81 of 2073 patients), respectively (hazard ratio, 0.59; 95% CI, 0.41-0.84; P = .004). Although there was a higher rate of ICA and coronary revascularization in the CTA group than in the standard-care group in the first few months of follow-up, the overall rates were similar at 5 years, with ICA performed in 491 patients and 502 patients in the CTA vs standard-care groups, respectively (hazard ratio, 1.00; 95% CI, 0.88-1.13). Similarly, coronary revascularization was performed in 279 patients in the CTA group and in 267 patients in the standard-care group (hazard ratio, 1.07; 95% CI, 0.91-1.27). There were, however, more preventive therapies initiated in patients in the CTA group than in the standard-care group (odds ratio, 1.40; 95% CI, 1.19-1.65).

Conclusion: In patients with stable chest pain, the use of CTA in addition to standard care resulted in a significantly lower rate of death from coronary heart disease or nonfatal myocardial infarction at 5 years; the main contributor to this outcome was a reduced nonfatal myocardial infarction rate. There was no difference in the rate of coronary angiography or coronary revascularization between the 2 groups at 5 years.

Pages

Recommended Reading

Lowering BP according to newest guidance would cut CV events
Journal of Clinical Outcomes Management
Pfizer recalls more quinapril because of potential carcinogen
Journal of Clinical Outcomes Management
Will you have cardiac arrest? New tech may predict if and when
Journal of Clinical Outcomes Management
Cutting dementia risk in AFib: Does rhythm control strategy matter?
Journal of Clinical Outcomes Management
‘Embarrassing’: High-intensity statin uptake in ASCVD patients ‘terrible’
Journal of Clinical Outcomes Management
Takotsubo syndrome also linked to happy life events
Journal of Clinical Outcomes Management
Mixing BP meds with NSAID may be ‘triple whammy’ for kidneys
Journal of Clinical Outcomes Management
ESG’s cardiometabolic benefits last 5 years
Journal of Clinical Outcomes Management
SGLT2 inhibitors as first-line therapy in type 2 diabetes?
Journal of Clinical Outcomes Management
Paradigm-challenging heart failure treatment strategy hopeful in early trial
Journal of Clinical Outcomes Management